Jessica, Author at Quantum-Si

Next-Gen Protein Sequencing to Detect Disease-Relevant Proteoforms

Dr. Gloria Sheynkman’s presentation at the Festival of Genomics highlights the importance of detecting protein isoforms for understanding human traits and diseases. She introduces a novel long-read proteogenomics workflow to enhance protein isoform detection. Additionally, she describes how the Platinum® next-gen protein sequencer offers single-molecule protein sequencing technology with high sensitivity and resolution. Platinum provides […]

Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization

QUANTUM-SI HOSTS WEBINAR ON ADVANCES IN PROTEIN IDENTIFICATION AND CHARACTERIZATION Company to hold webinar with Select Science on Friday, October 6, 2023 at 11 a.m. ET WHAT: The protein sequencing company, Quantum-Si, will discuss their novel next-generation protein sequencing platform, Platinum™, and how it can be used to identify proteins with single-molecule resolution and complement […]

Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board

The Protein Sequencing Company™ Commercializing the Industry’s First System to Enable Next-Generation, Single-Molecule Protein Sequencing Will Serve on HUPO’s Industrial Advisory Board GUILFORD, Conn.–(BUSINESS WIRE)–Dec. 8, 2022– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it has joined the Human Proteome Organization (HUPO) Industrial Advisory Board (IAB), an […]

Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference

GUILFORD, Conn.–(BUSINESS WIRE)– Jan. 10, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that management will discuss the following business updates at the 40th Annual J.P. Morgan Healthcare Conference. Commercial update Quantum-Si has established list prices for its end-to-end protein sequencing platform as follows: […]

Quantum-Si Signs Lease for New Headquarters in New Haven

Quantum-Si will begin relocating to the landmark Winchester Works site in the first half of 2022 GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it has entered into a lease agreement with Winchester Office LLC to develop a new […]